Skip to main content

Alkermes Shares Immuno Oncology Clinical Trial Research

By: 3BL Media

SOURCE: Alkermes

DESCRIPTION:

We are pleased to share clinical trial data on our investigational #immunooncology therapy and are excited to be a part of the 17th EADO Congress and 2021 World Mobile Congress Interactive Virtual Meeting. https://worldmelanoma2021.com/

Tweet me: .@Alkermes is pleased to share clinical trial data on their investigational #immunooncology therapy at the 17th EADO Congress and #WMC21 Interactive Virtual Meeting. https://bit.ly/3mLtdyG

KEYWORDS: NASDAQ: ALKS, Alkermes, Immuno-Oncology, 17th EADO Congress, 2021 World Mobile Congress Interactive Virtual Meeting

Recent Quotes

View More
Symbol Price Change (%)
AMZN  215.11
+2.07 (0.97%)
AAPL  264.13
+11.84 (4.69%)
AMD  242.28
+9.20 (3.95%)
BAC  52.20
+0.92 (1.80%)
GOOG  256.85
+3.06 (1.21%)
META  730.96
+14.05 (1.96%)
MSFT  517.03
+3.45 (0.67%)
NVDA  184.14
+0.92 (0.50%)
ORCL  277.70
-13.61 (-4.67%)
TSLA  442.74
+3.43 (0.78%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.